Inhibition of cyclooxygenase-2 prevents intra-abdominal adhesions by decreasing activity of peritoneal fibroblasts

Drug Des Devel Ther. 2015 Jun 15:9:3083-98. doi: 10.2147/DDDT.S80221. eCollection 2015.

Abstract

Background: Postoperative intra-abdominal adhesions are common complications after abdominal surgery. The exact molecular mechanisms that are responsible for these complications remain unclear, and there are no effective methods for preventing adhesion formation or reformation. The aim of the study reported here was to investigate the preventive effects and underlying potential molecular mechanisms of selective cyclooxygenase-2 (COX-2) inhibitors in a rodent model of postoperative intra-abdominal adhesions.

Materials and methods: The expression of COX-2 in postoperative intra-abdominal adhesions and normal peritoneal tissue was examined by immunohistochemistry and Western blot analysis. Assays were performed to elucidate the effect of COX-2 inhibition on hypoxia-induced fibroblast activity in vitro and on intra-abdominal adhesion formation in vivo.

Results: Hypoxia-induced COX-2 expression in peritoneal fibroblasts was increased in postoperative intra-abdominal adhesions. Inhibition of COX-2 attenuated the activating effect of hypoxia on normal peritoneal fibroblasts in vitro. Data indicate that selective COX-2 inhibitor prevents in vivo intra-abdominal adhesion by inhibition of basic fibroblast growth factor and transforming growth factor-beta expression, but not through an antiangiogenic mechanism. Furthermore, using selective COX-2 inhibitors to prevent intra-abdominal adhesions did not adversely affect the weight, bowel motility, or healing of intestinal anastomoses in a rat model.

Conclusion: These results show that hypoxia-induced COX-2 expression in peritoneal fibroblasts is involved in the formation of intra-abdominal adhesions. Inhibition of COX-2 prevents postoperative intra-abdominal adhesions through suppression of inflammatory cytokines.

Keywords: COX-2; COX-2 inhibitors; hypoxia; postoperative adhesions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdominal Wall / pathology
  • Anastomosis, Surgical
  • Animals
  • Body Weight
  • Cell Hypoxia / drug effects
  • Cyclooxygenase 2 / biosynthesis
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 Inhibitors / therapeutic use*
  • Fibroblast Growth Factor 2 / antagonists & inhibitors
  • Fibroblasts / drug effects*
  • Gastrointestinal Motility / drug effects
  • Humans
  • Hypoxia / pathology
  • Peritoneal Cavity / cytology*
  • Postoperative Complications / prevention & control
  • Rats
  • Rats, Sprague-Dawley
  • Tissue Adhesions / etiology
  • Tissue Adhesions / prevention & control*
  • Transforming Growth Factor beta / antagonists & inhibitors
  • Wound Healing / drug effects

Substances

  • Cyclooxygenase 2 Inhibitors
  • Transforming Growth Factor beta
  • Fibroblast Growth Factor 2
  • Cyclooxygenase 2